Mark K. Ferguson to Cost-Benefit Analysis
This is a "connection" page, showing publications Mark K. Ferguson has written about Cost-Benefit Analysis.
Connection Strength
0.253
-
Outpatient Thoracoscopic Mediastinal Biopsy: A Safe and Cost-Effective Approach. Ann Thorac Surg. 2020 11; 110(5):1726-1729.
Score: 0.155
-
Sleeve lobectomy or pneumonectomy: optimal management strategy using decision analysis techniques. Ann Thorac Surg. 2003 Dec; 76(6):1782-8.
Score: 0.049
-
Optimal management when unsuspected N2 nodal disease is identified during thoracotomy for lung cancer: cost-effectiveness analysis. J Thorac Cardiovasc Surg. 2003 Dec; 126(6):1935-42.
Score: 0.049